GPT and cancer: Haematological liver (AST, and ALT) and renal (BUN, and Creatinine) and both hepatic and renal (CPK) biomarkers have served as routine indicators of biosafety of any treatment given at the clinic when anticancer drugs are administered to cancer patients.